Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Net revenue $ 153,000 $ 293,000
Cost of sales 298,000 468,000
Gross loss (145,000) (175,000)
Operating expenses:    
Selling and administrative expenses 687,000 635,000
Research and development 478,000 294,000
Total operating expenses 1,165,000 929,000
Operating loss (1,310,000) (1,104,000)
Other income (expense):    
Change in fair value of derivative liabilities 11,000
Interest expense (136,000) (42,000)
Other (44,000)
Net loss $ (1,446,000) $ (1,179,000)
Net loss per share - basic and diluted (in dollars per share) $ (0.06) $ (0.05)
Weighted average number of common shares outstanding - basic and diluted (in shares) 25,086,794 23,086,349